![]() |
市场调查报告书
商品编码
2008721
兽医诊断市场报告:按产品类型、技术、动物种类、疾病、最终用户和地区划分(2026-2034 年)Veterinary Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2026-2034 |
||||||
2025年全球兽医诊断市场规模达75亿美元。展望未来,IMARC集团预测,该市场将在2026年至2034年间以6.42%的复合年增长率成长,到2034年达到134亿美元。北美地区凭藉其完善的兽医基础设施、不断普及的尖端诊断技术以及对动物保健日益增长的重视,成为推动市场成长的主要力量。推动市场发展的关键因素包括宠物数量的增长、宠物预防保健需求的增加以及人们对通用感染疾病(可在动物和人类之间传播)认识的提高。
人们对动物健康重要性的认识不断提高,促使人们更加关注疾病的快速诊断和预防。宠物饲主、畜牧养殖户和兽医专业人员越来越重视早期发现和定期健康检查,以确保动物健康、降低治疗成本并延长动物寿命和提高生产力。此外,政府和产业为加强兽医保健系统所做的努力也推动了诊断技术的应用。促进疾病监测、强制检测和生物安全的政策凸显了诊断在保护公众健康和动物福利方面的重要性,从而推动了私营和机构兽医部门的需求。此外,自动化、分子诊断工具和数据分析等诊断技术的不断进步,显着提高了兽医检测的效率、准确性和可靠性。这些进展使得疾病检测更加精准、流程更加简化、检测更加便捷,从而使诊断技术成为现代兽医保健和管理的重要组成部分。
快速准确检测的需求
兽医越来越依赖能够提供快速且准确结果的诊断工具,以支援快速的临床决策。在疾病快速进展的情况下,接受结果的延迟可能会影响治疗效果和动物的康復。对快速诊断结果的需求推动了相关技术的研发和应用,这些技术能够在临床环境中即时提供信息,并在检查室中快速处理样本。高精度设备确保了评估的准确性,并降低了误诊和不必要治疗的可能性。这种对速度和准确性的关注提高了临床效率,增强了客户的信任,并促进了患者治疗效果的改善。随着临床环境中时间限制的日益普遍,各种兽医机构对能够提供快速可靠资讯的诊断技术的需求也不断增长。 2024年,硕腾宣布在全球推出其新型人工智慧血液检测设备Vetscan OptiCell™,该设备于2025年1月25日至29日在奥兰多举行的VMX展会上首次亮相。这款无萤幕、卡式设备结合了黏弹性聚焦和人工智慧技术,可提供快速且准确的CBC(血液常规检查)结果。
扩大兽医医学教育和临床培训
兽医教育的进步和对临床培训的重视正在加速诊断技术融入日常兽医诊疗。如今,兽医学院和训练中心强调诊断工具、实验室分析和实证治疗方案製定的实务经验。这种经验影响新兽医的期望和临床行为,使他们在执业之初就拥有扎实的诊断程序基础。因此,诊断技术日益被视为临床评估和决策中的“必备工具”,而非“可有可无的工具”。继续教育计画的普及确保经验丰富的兽医能够及时了解新兴技术和诊断方法。这种持续学习的文化提升了诊断在兽医诊疗中的重要性,并促进了创新解决方案的采用。教育体系透过不断强调适当检测的重要性,正在培养更多以诊断为导向的兽医专业人才。
诊断技术的技术创新与进步
临床生物化学、分子检测和数位影像等领域的持续进步,不断提升诊断能力的准确性、速度和范围。这些进步提高了检测结果的可靠性和准确性,使兽医能够做出更明智的临床决策。此外,与数位平台的集成,有助于高效的数据处理、快速的结果分析以及对动物健康的长期监测。自动化程度的提高和易用性的增强,也使兽医更容易使用诊断工具,有助于提高诊所管理效率和服务品质。随着技术的进步,兽医诊断领域日益复杂,能够实现更早的干预和个人化护理。顺应这一趋势,Center Point Bio-Tech 于 2024 年在奥兰多举行的 VMX 2024 上推出了其先进的兽医诊断系统 AlphaION,并获得了超出预期的订单。 AlphaION 结合了人工智慧、自动化和表面声波 (SAW) 成像等创新技术,扩展了诊所内的诊断能力。这使得对更多种类的动物进行更快、更准确、更有经济的诊断成为可能。
对动物保健的投资和基础设施的扩建
公营和私营部门都在加大投入,以加强兽医基础设施建设、促进疾病控制并提升诊断能力。这体现在现代化检测设施的不断发展、兽医教育的提升以及先进检测设备的普及应用。例如,2024年,西孟加拉邦畜牧发展公司在其位于卡利亚尼的CLART中心推出了新的宠物诊断服务。加尔各答及其周边地区的宠物饲主可以线上预约上门采集检体,并在政府检测机构进行检测。这项服务还包括在盐湖城和巴拉萨特的固定采集点提供免费检测。完善的基础设施能够提升诊断能力、改善服务品质并确保可靠的品质保证。随着动物健康对公共卫生、食品安全和经济永续性等更广泛领域的影响日益受到重视,诊断正成为关注的焦点。
对复杂疾病早期检测的需求日益增长
随着人们对动物慢性病和潜在危及生命的疾病的认识不断提高,兽医和宠物饲主都在寻求能够在出现严重临床症状之前检测出异常的诊断方法。先进的诊断设备使专业人员能够评估器官功能、识别细胞变化并确定能够实现快速准确干预的指标。这种向快速诊断的转变改善了治疗效果,减少了侵入性手术,并提高了动物的生活品质。这种向预防性和精准医疗的转变凸显了诊断在临床过程中的重要性,并促进了在各种诊疗环境中持续使用常规和专业诊断服务。 2024年,玛氏科学与诊断公司旗下的安泰科技(Antech)在北美宣布推出两项兽医创新技术:AIS RapidRead和Nu.Q®犬类癌症检测。 AIS RapidRead利用人工智慧技术对放射影像进行近乎即时的分析,而Nu.Q®则可实现犬类癌症的快速筛检。这两项工具旨在加快诊断速度、提高准确性并改善治疗效果。
人们越来越关注畜牧业健康管理
随着对高品质动物产品的需求不断增长,生产者越来越多地利用诊断解决方案来降低疾病风险、提高繁殖效率并确保符合监管要求。透过诊断进行定期健康评估有助于维护生物安全、最大限度地减少疾病造成的经济损失并促进永续农业实践。因此,诊断技术正被纳入畜群健康管理倡议,尤其是在商业性农业实践中。加强监测和快速疾病检测有助于主动预防,并减少对紧急治疗的依赖。评估整个畜群的健康状况、监测表现指标以及识别无症状健康问题的能力正成为生产者的宝贵资源。在全球畜牧业面临着既要满足食品供应需求又要保障动物福利的压力之际,诊断技术作为一种预防和控製手段的重要性日益凸显。
The global veterinary diagnostics market size reached USD 7.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.42% during 2026-2034. North America dominates the market owing to its well-established veterinary infrastructure, rising adoption of state-of-the-art diagnostic technologies, and an increasing emphasis on animal health management. The growing number of pet ownerships, increasing demand for preventive care of pets, and rising awareness about zoonotic diseases, which can be transmitted between animals and humans, are some of the major factors propelling the market.
The growing acknowledgment of the significance of animal health is resulting in heightened focus on prompt diagnosis and disease prevention. Pet parents, livestock farmers, and veterinary specialists are increasingly prioritizing early detection and regular check-ups to ensure health, lower treatment expenses, and enhance animal longevity and productivity. Moreover, initiatives by both the government and industry to enhance veterinary health systems are encouraging the adoption of diagnostics. Policies that promote disease surveillance, compulsory testing, and biosecurity strengthen the importance of diagnostics in safeguarding public health and animal welfare, catalyzing the demand in both private and institutional veterinary care environments. Apart from this, ongoing advancements in diagnostic techniques, such as automation, molecular tools, and data analysis, are greatly enhancing the efficiency, precision, and dependability of veterinary testing. These advancements allow for more accurate disease detection, streamlined processes, and increased accessibility of tests, positioning diagnostics as a key element of contemporary veterinary care and administration.
Demand for Fast and Accurate Testing
Veterinary practitioners are increasingly depending on diagnostic tools that provide swift and precise results to aid prompt clinical decision-making. In rapidly advancing cases, delays in receiving test results can jeopardize treatment efficacy and animal recuperation. The need for quick diagnostic results is leading to the creation and use of technologies that deliver instant information at the point of care or via expedited lab processing. High-precision instruments guarantee accurate evaluations, decreasing the chances of incorrect diagnoses and superfluous procedures. This focus on promptness and precision boosts clinical productivity, increases client trust, and fosters improved patient results. With ongoing time-sensitive situations in practices, the demand for diagnostics that can provide quick and reliable information is growing within different veterinary care environments. In 2024, Zoetis announced the global launch of its new AI-powered hematology analyzer, Vetscan OptiCell(TM), debuting at VMX in Orlando from January 25-29, 2025. The screenless, cartridge-based device combined viscoelastic focusing and AI to deliver rapid, accurate CBC results.
Increase in Veterinary Education and Clinical Training
The development of veterinary education and the focus on clinical training are facilitating the incorporation of diagnostics into routine veterinary practice. Veterinary colleges and training centers currently prioritize practical experience with diagnostic tools, lab analysis, and evidence-based treatment planning. This exposure influences the expectations and clinical behaviors of novice professionals, who begin their practice with a solid grounding in diagnostic procedures. As a result, diagnostics are considered essential rather than optional tools for clinical assessment and decision-making. The rising availability of continuing education programs also ensures that established practitioners stay informed about emerging technologies and diagnostic methods. This culture of continuous learning enhances the importance of diagnostics in the profession and encourages the embrace of innovative solutions. The educational system, by consistently emphasizing the importance of proper testing, fosters a more diagnostics-focused veterinary workforce.
Technological Innovation and Diagnostic Advancements
Ongoing advancements in fields like clinical biochemistry, molecular testing, and digital imaging are enhancing the accuracy, rapidity, and range of diagnostic abilities. These advancements are improving the dependability and precision of test outcomes, allowing veterinarians to make better-informed clinical choices. Additionally, integration with digital platforms facilitates efficient data handling, quick analysis of results, and improved monitoring of animal health over time. Moreover, automation and enhanced usability are making diagnostic tools more available to veterinary practitioners, aiding in efficient practice management and elevated service quality. With the ongoing advancements in technology, the field of veterinary diagnostics is becoming increasingly complex, allowing for earlier interventions and tailored care. In line with this trend, in 2024, Center Point Bio-Tech launched its advanced veterinary diagnostic system, AlphaION, at VMX 2024 in Orlando, surpassing order expectations. AlphaION combined AI, automation, and innovations like surface acoustic wave (SAW) testing to expand in-clinic diagnostic capabilities. It enabled faster, more accurate, and cost-effective diagnostics for various animal species.
Expanding Animal Health Investments and Infrastructure
The public and private sectors are investing more resources to enhance veterinary infrastructure, advance disease control initiatives, and boost diagnostic capabilities. This is evident in the evolution of contemporary laboratories, improved education for veterinary practitioners, and the broad access to sophisticated testing equipment. For example, in 2024, the West Bengal Livestock Development Corporation launched a new pet diagnostic service at its CLART facility in Kalyani. Pet parents in Kolkata and nearby suburbs could book home sample collections online, with testing conducted at the government lab. The initiative included free testing at static collection points in Salt Lake and Barasat. A robust infrastructure enables increased diagnostic capacity, enhanced service delivery, and reliable quality assurance. With the growing recognition of the wider effects of animal health, particularly regarding public health, food safety, and economic viability, diagnostics are emerging as a key focus.
Rising Need for Early Detection of Complex Conditions
With the growing awareness about chronic and possibly life-threatening conditions in animals, veterinarians and pet parents are pursuing diagnostic options that can detect irregularities prior to the onset of serious clinical symptoms. Sophisticated testing instruments allow professionals to assess organ functionality, recognize cellular modifications, and pinpoint indicators that facilitate prompt, focused interventions. This move towards prompt diagnosis enhances treatment results, reduces invasive procedures, and improves the quality of life for animals. The shift towards proactive and precision-oriented veterinary care highlights the significance of diagnostics in clinical processes, promoting continued use of both routine and specialized testing services in various practice types. In 2024, Antech, part of Mars Science & Diagnostics, announced two new veterinary innovations in North America, including AIS RapidRead and the Nu.Q(R) Canine Cancer Test. AIS RapidRead used AI to deliver near-instant radiology insights, while Nu.Q(R) offered rapid cancer screening for dogs. Both tools aimed to improve diagnostic speed, accuracy, and care outcomes.
Growing Focus on Livestock Health Management
With the rising demand for premium animal-based food products, producers are progressively utilizing diagnostic solutions to mitigate disease risk, improve reproductive efficiency, and maintain regulatory compliance. Routine health evaluations via diagnostics aid in preserving biosecurity, minimizing financial losses from diseases, and promoting sustainable agricultural methods. This is resulting in the incorporation of diagnostics into herd health initiatives, especially in commercial farming practices. Enhanced monitoring and prompt disease detection lead to improved preparation and decreased dependence on urgent care options. The capability to assess general herd health, monitor performance metrics, and identify subclinical issues is emerging as a useful resource for producers. As the global livestock sector faces pressure to satisfy food supply demands without jeopardizing animal welfare, the importance of diagnostics as a preventive and management resource is becoming more vital.
Kits and reagents dominate the market
Kits and reagents play a crucial role in veterinary diagnostics and provide essential tools and substances for conducting various diagnostic tests. They include pre-packaged reagents and instructions for conducting tests, such as enzyme-linked immunosorbent assays (ELISAs) or polymerase chain reaction (PCR) assays. The reagents in these kits are designed to detect specific pathogens or disease markers, allowing veterinarians to diagnose infectious diseases spontaneously and accurately in animals. They are also used to measure parameters, such as complete blood counts, blood chemistries (including liver and kidney function), electrolyte levels, and blood clotting abilities. They assist in detecting abnormalities, such as the presence of bacteria, parasites, blood, or abnormal levels of certain chemicals or metabolites.
Clinical biochemistry holds the largest share in the market
Clinical biochemistry is a fundamental component of veterinary diagnostics that involves the analysis of blood and other body fluids to assess the physiological and biochemical status of animals. It provides valuable information about organ function, metabolic processes, and the presence of diseases or abnormalities. It helps measure a wide range of parameters, including enzymes, electrolytes, proteins, metabolites, hormones, and waste products. It encompasses various tests, which are conducted using specialized laboratory equipment and reagents. It also focuses on providing quantitative data that helps veterinarians in the diagnosis, monitoring, and treatment of various conditions. Furthermore, by evaluating the levels of specific analytes in the blood, such as liver enzymes, kidney function markers (creatinine), glucose, albumin, and electrolytes (sodium and potassium), clinical biochemistry aids in the detection of organ dysfunction, nutritional imbalances, endocrine disorders, and metabolic abnormalities in animals.
Livestock animals hold the maximum share of the market
Livestock animals, such as cattle, pigs, sheep, and poultry, require veterinary diagnostics as it helps identify and diagnose diseases effectively. Early detection is crucial for implementing appropriate control measures to restrict the spread of infectious diseases within herds or flocks. Besides this, diagnostic tests enable veterinarians to accurately identify the causative agents, determine the extent of disease prevalence, and guide the implementation of effective treatment and preventive strategies. Veterinary diagnostic testing also helps assess the health and productivity of individual animals and the overall herd or flock. By monitoring various parameters, such as blood chemistry, fecal quality, and growth rates, veterinarians can identify and address health issues that may affect production efficiency, including nutritional deficiencies, parasitic infections, metabolic disorders, and respiratory diseases.
Non-infectious diseases account for the majority of market share
Veterinary diagnostics play a crucial role in identifying infectious diseases in animals, as accurate and timely diagnosis is essential for appropriate treatment and control measures. It is essential for disease surveillance and monitoring in animal populations. By conducting diagnostic tests on individual animals or within herds or flocks, veterinarians can assess the prevalence, spread, and impact of infectious diseases. It also aids in identifying various zoonotic diseases in animals, helping prevent or minimize the transmission of pathogens from animals to humans. By diagnosing and managing infectious diseases in animals, veterinary diagnostics contribute to protect public health and prevent the spread of zoonotic infections.
Reference laboratories hold the largest share in the market
Reference laboratories play a vital role in veterinary diagnostics by providing specialized and advanced diagnostic services to support veterinarians, clinics, and research institutions. They are equipped with state-of-the-art technology, highly trained personnel, and expertise in a wide range of veterinary diagnostic disciplines. They offer a comprehensive number of diagnostic tests that may not be available at local veterinary clinics or laboratories. They often possess a broader test menu and the capacity to perform essential tests that require specialized equipment, techniques, or expertise. Reference laboratories can perform highly specific and sensitive tests to detect infectious agents, identify genetic disorders, diagnose complex diseases, and assess the overall health status of animals.
North America exhibits a clear dominance, accounting for the largest veterinary diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the increase in veterinary specialty practices and referral centers. Besides this, the rising focus on pet health and wellness and advanced veterinary medicine is propelling the growth of the market.
Another contributing aspect is the increasing demand for preventive healthcare, early disease detection, and personalized treatment options to ensure their pets lead long and healthy lives is offering a favorable veterinary diagnostics market outlook.
Asia Pacific is estimated to expand further in this domain due to rising adoption of pets among millennials. Besides this, the increasing expansion of livestock and aquaculture industries is bolstering the growth of the market.
Key market players in the market are implementing various strategies and initiatives to improve their business. They are investing in research and development (R&D) activities to innovate and develop new diagnostic technologies, tests, and products. They are also focusing on improving the accuracy, efficiency, and speed of veterinary diagnostic tests, as well as expanding the range of diseases and conditions that can be diagnosed. Top companies are actively pursuing strategic partnerships and acquisitions to expand their product offerings, geographical reach, and market share. They are also providing telemedicine services to pet owners, comprising of consultation, monitoring, and remote diagnostic in certain scenarios. Leading companies are embracing artificial intelligence (AI), machine learning (ML), and molecular diagnostics to improve their product offerings and service delivery.